ITMCTR2000004110RecruitingPhase 4
Clinical study of Dan Zhi Xiaoyao Tablets in the treatment of burning mouth syndrome: a randomized controlled trial
The Ninth People's Hospital affiliated to Shanghai Jiaotong University Medical College0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to 75 (—)
- Sex
- All
Inclusion Criteria
- •1. Above 18 years old, below 75 years old.
- •2. Gender is not limited.
- •3. Meet the diagnostic criteria of BMS defined by the International Association for The Study of Pain:A. The symptoms lasted for more than 2 h per day for more than 3 months in total, and the pain was characterized by burning sensation and dry oral mucosa.B. Normal appearance of oral mucosa and normal clinical examination.C. There is no more suitable diagnosis in the Third edition of the International Classification of Headache Diseases.
- •4. In line with the syndrome of qi depression and fire clamps deficiency: irritable, or from night sweat, or headache, acerbity eyes, or cheeks, dry mouth, or irregular menstruation, lower abdomen pain, or urination pain, red tongue, thin yellow coating on the tongue, pulse string or deficiency.
- •5. Did not receive any treatment for BMS in 1 month.
- •6. VAS score (visual simulation score) is greater than or equal to 2.
- •7. Willing to sign written informed consent after full explanation.
Exclusion Criteria
- •1. Other oral mucous membrane diseases.
- •2. Systemic diseases, such as diabetes, anemia, nutritional deficiencies (vitamins, folic acid, Fe, Zn, etc.), thyroid dysfunction, allergy to food or dental materials, autoimmune diseases, mental diseases, Sjogren's syndrome, etc.
- •3. Bad oral habits such as biting cheek, tongue, etc.
- •4. There are local stimulation factors, such as sharp tooth tip, bad repair, chemical and physical injury.
Investigators
Similar Trials
Recruiting
Not Applicable
Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19)ITMCTR2000003225nion Hospital of Tongji Medical College, Huazhong University of Science and Technology
Recruiting
Phase 1
Clinical Observation of Zihua Xiaoying Decoction in Treating Hashimoto Thyroiditis with Thyroid Nodules of Phlegm and Blood Stasis Type Clinical Observation of Zihua Xiaoying Decoction in Treating Hashimoto Thyroiditis with Thyroid Nodules of Phlegm and Blood Stasis TypeHashimoto's thyroiditis with thyroid nodulesITMCTR2100004916Weishan People's Hospital
Not yet recruiting
Phase 4
Clinical trial of Zhen Shu Tiu Zhi Capsule in treating diabetic damp heat syndrome and study on biological basis of damp heat syndrome of glycolipid metabolic diseasesDiabetesITMCTR2200005519Dongzhimen Hospital, Beijing University of Chinese Medicine
Recruiting
Phase 1
Clinical study on Yixiao Decoction in the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunctioType 2 DiabetesITMCTR2100004708Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Not yet recruiting
Phase 1
Clinical study for the 'Wen-Yang Tong-Du' medicine pot in the treatment of ankylosing spondylitisAnkylosing SpondylitisITMCTR1900002422Gansu Provincial Hospital of TCM
